New comprehensive report on pediatric long COVID symptoms published

Up to 5.8 million children and youth in the U.S. have experienced symptoms of COVID-19 that persisted long after initial infection.

Boosting fitness levels linked to lower prostate cancer risk

A study in Swedish men finds that increasing cardiorespiratory fitness (CRF) over time is associated with a lower risk of prostate cancer incidence, highlighting the

February 5, 2024

Disney Drops Bid to Get Doc’s Allergy-Death Lawsuit Tossed Because of Disney+ Plan

Disney will no longer ask a Florida court to dismiss a wrongful death lawsuit on the grounds that the victim’s family had signed up for

August 21, 2024

Risk adjusted net present value: What is the current valuation of Johnson & Johnson’s Nipocalimab?

Nipocalimab is a monoclonal antibody commercialized by Johnson & Johnson, with a leading Phase III program in Acquired (Autoimmune) Hemolytic Anemia.

March 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.